Chas P. Smith & Associates (CPS)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Sell |
|
|||||
|
2025
Q1 | $419K | Sell |
|
|||||
|
2024
Q4 | $413K | Sell |
|
|||||
|
2024
Q3 | $511K | Sell |
|
|||||
|
2024
Q2 | $410K | Sell |
|
|||||
|
2024
Q1 | $540K | Buy |
|
|||||
|
2023
Q4 | $363K | Buy |
|
|||||
|
2023
Q3 | $334K | Sell |
|
|||||
|
2023
Q2 | $551K | Buy |
|
|||||
|
2023
Q1 | $545K | Sell |
|
|||||
|
2022
Q4 | $631K | Buy |
|
|||||
|
2022
Q3 | $617K | Buy |
|
|||||
|
2022
Q2 | $382K | Sell |
|
|||||
|
2022
Q1 | $364K | Sell |
|
|||||
|
2021
Q4 | $315K | Buy |
|
|||||
|
2021
Q3 | $294K | Sell |
|
|||||
|
2021
Q2 | $336K | Sell |
|
|||||
|
2021
Q1 | $319K | Hold |
|
|||||
|
2020
Q4 | $314K | Sell |
|
|||||
|
2020
Q3 | $306K | Sell |
|
|||||
|
2020
Q2 | $313K | Hold |
|
|||||
|
2020
Q1 | $297K | Buy |
|
|||||
|
2019
Q4 | $329K | Hold |
|
|||||
|
2019
Q3 | $260K | Hold |
|
|||||
|
2019
Q2 | $233K | Sell |
|
|||||
|
2019
Q1 | $274K | Hold |
|
|||||
|
2018
Q4 | $298K | Sell |
|
|||||
|
2018
Q3 | $362K | Hold |
|
|||||
|
2018
Q2 | $323K | Sell |
|
|||||
|
2018
Q1 | $378K | Sell |
|
|||||
|
2017
Q4 | $426K | Hold |
|
|||||
|
2017
Q3 | $443K | Sell |
|
|||||
|
2017
Q2 | $454K | Sell |
|
|||||
|
2017
Q1 | $448K | Sell |
|
|||||
|
2016
Q4 | $513K | Sell |
|
|||||
|
2016
Q3 | $1.19M | Buy |
|
|||||
|
2016
Q2 | $669K | Sell |
|
|||||
|
2016
Q1 | $763K | Buy |
|
|||||
|
2015
Q4 | $667K | Sell |
|
|||||
|
2015
Q3 | $645K | Sell |
|
|||||
|
2015
Q2 | $727K | Sell |
|
|||||
|
2015
Q1 | $724K | Sell |
|
|||||
|
2014
Q4 | $686K | Hold |
|
|||||
|
2014
Q3 | $595K | Buy |
|
|||||
|
2014
Q2 | $561K | Sell |
|
|||||
|
2014
Q1 | $1.63M | Hold |
|
|||||
|
2013
Q4 | $1.66M | Buy |
|
|||||
|
2013
Q3 | $483K | Sell |
|
|||||
|
2013
Q2 | $502K | Buy |
|